Patents by Inventor Yuchen Sheng

Yuchen Sheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240126827
    Abstract: Systems and methods for efficiently identifying and extracting machine-actionable structured data from web documents are provided. The technology employs neural network architectures which process the raw HTML content of a set of seed websites to create transferrable models regarding information of interest. These models can then be applied to the raw HTML of other websites to identify similar information of interest. Data can thus be extracted across multiple websites in a functional, structured form that allows it to be used further by a processing system.
    Type: Application
    Filed: December 13, 2023
    Publication date: April 18, 2024
    Inventors: Ying Sheng, Yuchen Lin, Sandeep Tata, Nguyen Vo
  • Patent number: 8227612
    Abstract: The present invention discloses a quinoline compound represented by the formula A or pharmaceutically acceptable solvate, optical isomer or polymorph thereof, wherein X is S or O; M is H, Na+, NH4+ or Ca2+; each of R1, R2 and R3 is independently H, halogen, the group represented by formula D or formula E; R is H, halogen, C1˜C4 alkyl or C1˜C4 alkoxy. The present invention also discloses its pharmaceutical composition and the preparation method thereof and application in manufacturing a medicament for inhibiting HMG-CoA reductase or for the treatment and prophylaxis of the diseases which can be treated effectively by inhibiting HMG-CoA reductase. The quinloline compound and pharmaceutical composition thereof of the present invention have an excellent lipid reduction effect in vivo and can be applied for treatment of a hyperlipidemia-related disease.
    Type: Grant
    Filed: April 29, 2009
    Date of Patent: July 24, 2012
    Assignee: Shanghai Institute of Pharmaceutical Industry
    Inventors: Zhengyan Cai, Weicheng Zhou, Qun Hao, Zhenhua Shi, Yuchen Sheng, Mingyu Shi, Qingning Liang
  • Publication number: 20110021561
    Abstract: The present invention discloses a quinoline compound represented by the formula A or pharmaceutically acceptable solvate, optical isomer or polymorph thereof, wherein X is S or O; M is H, Na+, NH4+ or Ca2+; each of R1, R2 and R3 is independently H, halogen, the group represented by formula D or formula E; R is H, halogen, C1˜C4 alkyl or C1˜C4 alkoxy. The present invention also discloses its pharmaceutical composition and the preparation method thereof and application in manufacturing a medicament for inhibiting HMG-CoA reductase or for the treatment and prophylaxis of the diseases which can be treated effectively by inhibiting HMG-CoA reductase. The quinloline compound and pharmaceutical composition thereof of the present invention have an excellent lipid reduction effect in vivo and can be applied for treatment of a hyperlipidemia-related disease.
    Type: Application
    Filed: April 29, 2009
    Publication date: January 27, 2011
    Inventors: Zhengyan Cai, Weicheng Zhou, Qun Hao, Zhenhua Shi, Yuchen Sheng, Mingyu Shi, Qingning Liang